e-LEA3D
e-LEA3D performs computer-aided drug design by combining molecular fragment-based de novo design, virtual screening, and combinatorial library generation to identify and optimize molecular scaffolds and substituents.
Key Features:
- De Novo Drug Design Tool: Uses a heuristic approach based on genetic algorithms to optimize a user-specified scoring function that incorporates structure- and ligand-based evaluations, fits fragments or fragment combinations to QSAR models or protein binding sites, enables scaffold-hopping, and scans for substituents on user-specified scaffolds.
- Virtual Screening and Filtering Tool: Screens and filters uploaded compound libraries according to predefined criteria to prioritize candidates from large collections.
- Combinatorial Library Design Tool: Generates combinatorial libraries by combining user-drawn scaffolds with reactants sourced from chemical suppliers to produce diverse compound libraries.
Scientific Applications:
- Scaffold discovery and scaffold-hopping: Exploration and identification of novel molecular scaffolds through fragment recombination and scaffold-hopping strategies.
- QSAR- and structure-based ligand optimization: Optimization of ligands against QSAR models or protein binding sites using fragment-based design and scoring functions.
- Substituent scanning: Systematic scanning of substituents on specified scaffolds to expand chemical space and probe structure-activity relationships.
- Library prioritization: Prioritization and filtering of large compound libraries via virtual screening to identify promising candidates.
- Combinatorial library generation: Design of combinatorial libraries from scaffold and reactant combinations for subsequent evaluation and synthesis planning.
Methodology:
Heuristic genetic algorithms optimize user-specified scoring functions that combine structure- and ligand-based evaluations; fragments are fitted to QSAR models or protein binding sites; uploaded libraries undergo virtual screening and filtering; combinatorial libraries are generated by combining user-drawn scaffolds with reactants.
Topics
Details
- Tool Type:
- web application
- Operating Systems:
- Linux, Windows, Mac
- Added:
- 2/14/2017
- Last Updated:
- 11/25/2024
Operations
Publications
Douguet D. e-LEA3D: a computational-aided drug design web server. Nucleic Acids Research. 2010;38(Web Server):W615-W621. doi:10.1093/nar/gkq322. PMID:20444867. PMCID:PMC2896156.